Verfügbarkeit: Coagulation disorders :

Coagulation disorders :: quality in laboratory diagnosis /

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Laposata, Michael
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	New York : Demos Medical Pub., ©2011.
Schriftenreihe:	Diagnostic standards of care.
Schlagworte:	Blood coagulation disorders > Diagnosis. Diagnosis, Laboratory. Blood Coagulation Disorders > diagnosis Anticoagulants > therapeutic use Blood Coagulation > physiology Clinical Laboratory Techniques > methods Medical Errors > prevention & control Diagnostics biologiques. MEDICAL > Hematology. Blood coagulation disorders > Diagnosis Diagnosis, Laboratory
Online-Zugang:	Volltext
Beschreibung:	1 online resource (xii, 145 pages).
Bibliographie:	Includes bibliographical references and index.
ISBN:	9781617050220 1617050229

Internformat

MARC


LEADER	00000cam a2200000 a 4500
001	ZDB-4-EBA-ocn743802455
003	OCoLC
005	20241004212047.0
006	m o d
007	cr cnu---unuuu
008	110801s2011 nyu ob 001 0 eng d
040			\|a N$T \|b eng \|e pn \|c N$T \|d CDX \|d YDXCP \|d E7B \|d OCLCQ \|d GWM \|d OCLCQ \|d OCLCA \|d OCLCF \|d NLGGC \|d OCLCQ \|d D6H \|d AGLDB \|d OCLCO \|d JBG \|d OCLCO \|d TOA \|d OCLCO \|d PIFAG \|d OCLCO \|d WY@ \|d VTS \|d OCLCO \|d TOF \|d OCLCO \|d OCLCA \|d STF \|d OCLCO \|d M8D \|d OCLCO \|d OCLCA \|d OCLCO \|d OCLCQ \|d IOY \|d OCLCQ \|d OCLCO \|d OCLCQ \|d OCLCL
020			\|a 9781617050220 \|q (electronic bk.)
020			\|a 1617050229 \|q (electronic bk.)
020			\|z 9781933864822
020			\|z 1933864826
035			\|a (OCoLC)743802455
050		4	\|a RC647.C55 \|b L37 2011eb
060		4	\|a 2011 A-427
060		4	\|a WH 322 \|b L315c 2011
072		7	\|a MED \|x 038000 \|2 bisacsh
082	7		\|a 616.1/57075 \|2 22
049			\|a MAIN
100	1		\|a Laposata, Michael. \|0 http://id.loc.gov/authorities/names/n88088146
245	1	0	\|a Coagulation disorders : \|b quality in laboratory diagnosis / \|c Michael Laposata.
260			\|a New York : \|b Demos Medical Pub., \|c ©2011.
300			\|a 1 online resource (xii, 145 pages).
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
490	1		\|a Diagnostic standards of care
504			\|a Includes bibliographical references and index.
505	0		\|a Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.
588	0		\|a Print version record.
650		0	\|a Blood coagulation disorders \|x Diagnosis.
650		0	\|a Diagnosis, Laboratory. \|0 http://id.loc.gov/authorities/subjects/sh85037496
650	1	2	\|a Blood Coagulation Disorders \|x diagnosis
650	2	2	\|a Anticoagulants \|x therapeutic use
650	2	2	\|a Blood Coagulation \|x physiology
650	2	2	\|a Clinical Laboratory Techniques \|x methods
650	2	2	\|a Medical Errors \|x prevention & control
650		6	\|a Diagnostics biologiques.
650		7	\|a MEDICAL \|x Hematology. \|2 bisacsh
650		7	\|a Blood coagulation disorders \|x Diagnosis \|2 fast
650		7	\|a Diagnosis, Laboratory \|2 fast
758			\|i has work: \|a Coagulation disorders (Text) \|1 https://id.oclc.org/worldcat/entity/E39PCGYFqj4vFTT4CrGgKh7HBX \|4 https://id.oclc.org/worldcat/ontology/hasWork
776	0	8	\|i Print version: \|a Laposata, Michael. \|t Coagulation disorders. \|d New York : Demos Medical Pub., ©2011 \|z 9781933864822 \|w (DLC) 2010021811 \|w (OCoLC)632070602
830		0	\|a Diagnostic standards of care. \|0 http://id.loc.gov/authorities/names/n2010182185
856	4	0	\|l FWS01 \|p ZDB-4-EBA \|q FWS_PDA_EBA \|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=379209 \|3 Volltext
938			\|a Coutts Information Services \|b COUT \|n 18402442
938			\|a ebrary \|b EBRY \|n ebr10488686
938			\|a EBSCOhost \|b EBSC \|n 379209
938			\|a YBP Library Services \|b YANK \|n 6980096
994			\|a 92 \|b GEBAY
912			\|a ZDB-4-EBA
049			\|a DE-863

Datensatz im Suchindex

DE-BY-FWS_katkey	ZDB-4-EBA-ocn743802455
_version_	1816881766624919552
adam_text
any_adam_object
author	Laposata, Michael
author_GND	http://id.loc.gov/authorities/names/n88088146
author_facet	Laposata, Michael
author_role
author_sort	Laposata, Michael
author_variant	m l ml
building	Verbundindex
bvnumber	localFWS
callnumber-first	R - Medicine
callnumber-label	RC647
callnumber-raw	RC647.C55 L37 2011eb
callnumber-search	RC647.C55 L37 2011eb
callnumber-sort	RC 3647 C55 L37 42011EB
callnumber-subject	RC - Internal Medicine
collection	ZDB-4-EBA
contents	Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.
ctrlnum	(OCoLC)743802455
dewey-full	616.1/57075
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	616 - Diseases
dewey-raw	616.1/57075
dewey-search	616.1/57075
dewey-sort	3616.1 557075
dewey-tens	610 - Medicine and health
discipline	Medizin
format	Electronic eBook
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03791cam a2200613 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn743802455</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">110801s2011 nyu ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">CDX</subfield><subfield code="d">YDXCP</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">GWM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCF</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">D6H</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">JBG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">PIFAG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WY@</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TOF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">IOY</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781617050220</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1617050229</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781933864822</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1933864826</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)743802455</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC647.C55</subfield><subfield code="b">L37 2011eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2011 A-427</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WH 322</subfield><subfield code="b">L315c 2011</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">038000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.1/57075</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Laposata, Michael.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n88088146</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Coagulation disorders :</subfield><subfield code="b">quality in laboratory diagnosis /</subfield><subfield code="c">Michael Laposata.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">New York :</subfield><subfield code="b">Demos Medical Pub.,</subfield><subfield code="c">©2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 145 pages).</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Diagnostic standards of care</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Blood coagulation disorders</subfield><subfield code="x">Diagnosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diagnosis, Laboratory.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85037496</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Blood Coagulation Disorders</subfield><subfield code="x">diagnosis</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Anticoagulants</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Blood Coagulation</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Clinical Laboratory Techniques</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Medical Errors</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Diagnostics biologiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Hematology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Blood coagulation disorders</subfield><subfield code="x">Diagnosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diagnosis, Laboratory</subfield><subfield code="2">fast</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Coagulation disorders (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGYFqj4vFTT4CrGgKh7HBX</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Laposata, Michael.</subfield><subfield code="t">Coagulation disorders.</subfield><subfield code="d">New York : Demos Medical Pub., ©2011</subfield><subfield code="z">9781933864822</subfield><subfield code="w">(DLC) 2010021811</subfield><subfield code="w">(OCoLC)632070602</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Diagnostic standards of care.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010182185</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=379209</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">18402442</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10488686</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">379209</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">6980096</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection>
id	ZDB-4-EBA-ocn743802455
illustrated	Not Illustrated
indexdate	2024-11-27T13:17:56Z
institution	BVB
isbn	9781617050220 1617050229
language	English
oclc_num	743802455
open_access_boolean
owner	MAIN DE-863 DE-BY-FWS
owner_facet	MAIN DE-863 DE-BY-FWS
physical	1 online resource (xii, 145 pages).
psigel	ZDB-4-EBA
publishDate	2011
publishDateSearch	2011
publishDateSort	2011
publisher	Demos Medical Pub.,
record_format	marc
series	Diagnostic standards of care.
series2	Diagnostic standards of care
spelling	Laposata, Michael. http://id.loc.gov/authorities/names/n88088146 Coagulation disorders : quality in laboratory diagnosis / Michael Laposata. New York : Demos Medical Pub., ©2011. 1 online resource (xii, 145 pages). text txt rdacontent computer c rdamedia online resource cr rdacarrier Diagnostic standards of care Includes bibliographical references and index. Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents. Print version record. Blood coagulation disorders Diagnosis. Diagnosis, Laboratory. http://id.loc.gov/authorities/subjects/sh85037496 Blood Coagulation Disorders diagnosis Anticoagulants therapeutic use Blood Coagulation physiology Clinical Laboratory Techniques methods Medical Errors prevention & control Diagnostics biologiques. MEDICAL Hematology. bisacsh Blood coagulation disorders Diagnosis fast Diagnosis, Laboratory fast has work: Coagulation disorders (Text) https://id.oclc.org/worldcat/entity/E39PCGYFqj4vFTT4CrGgKh7HBX https://id.oclc.org/worldcat/ontology/hasWork Print version: Laposata, Michael. Coagulation disorders. New York : Demos Medical Pub., ©2011 9781933864822 (DLC) 2010021811 (OCoLC)632070602 Diagnostic standards of care. http://id.loc.gov/authorities/names/n2010182185 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=379209 Volltext
spellingShingle	Laposata, Michael Coagulation disorders : quality in laboratory diagnosis / Diagnostic standards of care. Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents. Blood coagulation disorders Diagnosis. Diagnosis, Laboratory. http://id.loc.gov/authorities/subjects/sh85037496 Blood Coagulation Disorders diagnosis Anticoagulants therapeutic use Blood Coagulation physiology Clinical Laboratory Techniques methods Medical Errors prevention & control Diagnostics biologiques. MEDICAL Hematology. bisacsh Blood coagulation disorders Diagnosis fast Diagnosis, Laboratory fast
subject_GND	http://id.loc.gov/authorities/subjects/sh85037496
title	Coagulation disorders : quality in laboratory diagnosis /
title_auth	Coagulation disorders : quality in laboratory diagnosis /
title_exact_search	Coagulation disorders : quality in laboratory diagnosis /
title_full	Coagulation disorders : quality in laboratory diagnosis / Michael Laposata.
title_fullStr	Coagulation disorders : quality in laboratory diagnosis / Michael Laposata.
title_full_unstemmed	Coagulation disorders : quality in laboratory diagnosis / Michael Laposata.
title_short	Coagulation disorders :
title_sort	coagulation disorders quality in laboratory diagnosis
title_sub	quality in laboratory diagnosis /
topic	Blood coagulation disorders Diagnosis. Diagnosis, Laboratory. http://id.loc.gov/authorities/subjects/sh85037496 Blood Coagulation Disorders diagnosis Anticoagulants therapeutic use Blood Coagulation physiology Clinical Laboratory Techniques methods Medical Errors prevention & control Diagnostics biologiques. MEDICAL Hematology. bisacsh Blood coagulation disorders Diagnosis fast Diagnosis, Laboratory fast
topic_facet	Blood coagulation disorders Diagnosis. Diagnosis, Laboratory. Blood Coagulation Disorders diagnosis Anticoagulants therapeutic use Blood Coagulation physiology Clinical Laboratory Techniques methods Medical Errors prevention & control Diagnostics biologiques. MEDICAL Hematology. Blood coagulation disorders Diagnosis Diagnosis, Laboratory
url	https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=379209
work_keys_str_mv	AT laposatamichael coagulationdisordersqualityinlaboratorydiagnosis

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Volltext öffnen

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge